Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Indeed, increased levels of SAM in arterial cord blood (irrespective of treatment) and venous cord blood (mainly in the NAC-arm), were observed in severe IPTB, as well as higher serine, homocysteine, and methionine in maternal blood, along with similar levels of cystathionine in both maternal and cord blood
The bottom line The peptide vote matters
Critical safety considerations for laboratory use include potential immunogenicity concernswith peptide therapeutics commonly showing injection site reactions (20-40% with subcutaneous administration) and possible antidrug antibody formationalong with theoretical concerns that pro-angiogenic properties could potentially influence experimental tumor models, requiring appropriate controls in oncology-related research
Ease of use across the entire platform Ease of use across the entire platform, communication is timely and extremely helpful
US$ 25.35
US$ 20.38
US$ 22.03
US$ 26.66
US$ 20.96
